Spinelab Raises Series C from BioMedInvest and VI Partners Leads (press release)
Spinelab AG, a privately held company, specialized in developing motion preserving stabilization systems for the spine, announced today that it has raised Swiss francs 4.7 million in a Series C financing round. Lead investors are BioMedInvest and VI Partners. Spinelab has raised Swiss francs 20 million since its first venture round end of 2006.
“Spinelab has rigorously documented the clinical performance of its flagship product, the motion preservation system Elaspine™, over the last three years. This new funds wi...
